A promising study hits a wall, not because the hypothesis was flawed, but because the foundational stepthe preparationwas compromised
Compounded tirzepatide is a customized version of the medication, prepared by our partner, Belmar Pharma Solutions
Post-operative patients receive tailored protocols that focus on faster healing and reduced complication risk
Safety Considerations: Tirzepatide is not recommended for those with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, a history of pancreatitis, or severe gastrointestinal disease
BPC-157 lacks FDA approval as a drug or dietary supplement ingredient approved for human administration
Risks include gastrointestinal side effects, pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumors